How Scientists Identify Carcinogens

This page explains how scientists decide whether something can cause cancer. It is for anyone trying to judge a new cancer headline.

Deciding whether something can cause cancer is detective work. Scientists gather three main kinds of evidence and weigh them together.

1. Human studies (epidemiology). Researchers compare groups of people with different exposures. They might compare workers exposed to a chemical with workers who were not, then track who develops cancer. This is the most direct evidence, but it is hard to do well. Cancer can take decades to appear. People are exposed to many things at once. Separating one cause from another is difficult.

2. Animal studies. Sometimes it would be unethical or impossible to expose people on purpose. Researchers then study laboratory animals. These studies can show whether an agent causes cancer, and at what doses. Results do not always transfer perfectly to humans, but a clear animal signal is an important warning.

3. Mechanism (how it works). Scientists also study how an agent behaves inside cells. Does it damage DNA, cause inflammation, or push cells to divide? Understanding the biology helps explain whether and how something could cause cancer in people.

A common misunderstanding is that one headline-making study "proves" something causes cancer. In reality, expert panels look at the whole body of evidence together. A single study is rarely enough, especially a small one. Reviewers ask whether findings hold up across many studies. They ask whether higher exposure leads to more cancer. And they ask whether the biology makes sense.

Two of the most influential groups are:

• The IARC Monographs program, part of the World Health Organization. It brings together international experts to review agents and place them in groups.
• The U.S. National Toxicology Program (NTP), which publishes the Report on Carcinogens.

Both do hazard identification. They judge whether something can cause cancer. They do not calculate your personal risk. Other agencies, such as the U.S. EPA, add risk assessments that estimate how much exposure leads to how much risk.

Science is not frozen. As better studies appear, agencies re-evaluate and sometimes change their conclusions. Coffee is a well-known example. In 2016, after reviewing more than a thousand studies, IARC moved coffee out of the "possibly carcinogenic" category to "not classifiable."

Changes like this are a sign the system is working. It follows the evidence rather than sticking to old assumptions.

When you see a new claim that something causes cancer, ask one question. Is this one study, or a considered judgment from an expert panel weighing all the evidence? The most reliable conclusions come from groups like IARC and the NTP. They review everything together and update as the science grows.